ENDPOINTS

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...

Feb 28, 2025 - 16:50
 0
Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics
Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...
Read More

Tags:

Previous Article

Shock discovery tears up the rules of time and space inside a computer

Next Article

A Simpler AI Melody Played at ViVE2025

Related Posts

FDA meeting to pick next winter's flu shot is canceled

FDA meeting to pick next winter's flu shot is canceled

Feb 27, 2025  0

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

Sanofi, Teva bolster case for IBD drug with Phase 2 dat...

Feb 24, 2025  0

Moderna earnings: Losses narrow as biotech cuts costs

Moderna earnings: Losses narrow as biotech cuts costs

Feb 14, 2025  0